6915 — Jiangxi Institute of Biological Products Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
HK$2.12bn
Enterprise Value
HK$1.64bn
Revenue
CNY235.41m

Annual balance sheet for Jiangxi Institute of Biological Products, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.2	56.9	73.8
Net Total Accounts Receivable
Net Total Receivables	75	69.2	107
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	194	192	257
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	273	258	269
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	502	488	560
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	139	83.4	61.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	140	84.3	62.3
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	362	403	498
Total Liabilities & Shareholders' Equity	502	488	560
Total Common Shares Outstanding